Average Cost-Effectiveness Ratio with Censored Data
暂无分享,去创建一个
[1] J. Kupersmith,et al. Covariate-adjusted cost–effectiveness ratios , 1999 .
[2] Xiao-Hua Zhou,et al. Nonparametric Statistical Methods for Cost‐Effectiveness Analyses , 2006, Biometrics.
[3] James B. Orlin,et al. Finding minimum cost to time ratio cycles with small integral transit times , 1993, Networks.
[4] Rupert G. Miller,et al. Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.
[5] A. Briggs,et al. Statistical Analysis of Cost-effectiveness Data: Willan/Statistical Analysis of Cost-effectiveness Data , 2006 .
[6] Hongwei Zhao,et al. A Study on Confidence Intervals for Incremental Cost‐Effectiveness Ratios , 2008, Biometrical journal. Biometrische Zeitschrift.
[7] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[8] P. Wakker,et al. Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.
[9] J. Gardiner,et al. On Parametric Confidence Intervals for the Cost‐Effectiveness Ratio , 2001 .
[10] Andrew R Willan,et al. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. , 2004, Health economics.
[11] A H Briggs,et al. Handling uncertainty in economic evaluations of healthcare interventions , 1999, BMJ.
[12] Hongwei Zhao,et al. On the equivalence of some medical cost estimators with censored data. , 2007, Statistics in medicine.
[13] N. Blomqvist,et al. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. , 1998, Statistics in medicine.
[14] Marianne Huebner,et al. 28 The cost-effectiveness ratio in the analysis of health care programs , 2000, Bioenvironmental and public health statistics.
[15] N Engl,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.
[16] A. Gafni,et al. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. , 2006, Social science & medicine.
[17] A I Mushlin,et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. , 1998, Circulation.
[18] M C Weinstein,et al. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.
[19] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[20] A. Mcguire,et al. Estimating medical care costs under conditions of censoring. , 2004, Journal of health economics.
[21] Milton C. Weinstein,et al. Recommendations for Reporting Cost-effectiveness Analyses , 1996 .
[22] A. Gafni,et al. Information created to evade reality (ICER): things we should not look to for answers. , 2006, PharmacoEconomics.
[23] Andrew H Briggs,et al. A Note on the Estimation of Confidence Intervals for Cost-Effectiveness When Costs and Effects Are Censored , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.
[24] J. Robins,et al. Estimation of Regression Coefficients When Some Regressors are not Always Observed , 1994 .
[25] R. Obenchain. Resampling and multiplicity in cost-effectiveness inference. , 1999, Journal of biopharmaceutical statistics.
[26] Somnath Datta,et al. The Kaplan–Meier Estimator as an Inverse-Probability-of-Censoring Weighted Average , 2001, The American statistician.
[27] E. Feuer,et al. Estimating medical costs from incomplete follow-up data. , 1997, Biometrics.
[28] A H Briggs,et al. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. , 1999, Statistics in medicine.
[29] C. Dewa,et al. A Clinician's Guide to Correct Cost-Effectiveness Analysis: Think Incremental Not Average , 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[30] Xiao-Hua Zhou,et al. A simulation study to compare methods for constructing confidence intervals for the incremental cost-effectiveness ratio , 2007, Health Services and Outcomes Research Methodology.
[31] B O'Brien,et al. Statistical analysis of cost effectiveness data. , 1999, The Journal of rheumatology.
[32] M. Weinstein,et al. Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.
[33] E. Laska,et al. The usefulness of average cost‐effectiveness ratios , 1997 .
[34] Anthony O'Hagan,et al. On estimators of medical costs with censored data. , 2004, Journal of health economics.
[35] D. Lin,et al. Linear regression analysis of censored medical costs. , 2000, Biostatistics.
[36] E. C. Fieller. SOME PROBLEMS IN INTERVAL ESTIMATION , 1954 .
[37] M Meisner,et al. Statistical inference for cost-effectiveness ratios. , 1997, Health economics.
[38] J. Baron,et al. Incremental and Average Cost‐Effectiveness Ratios: Will Physicians Make a Distinction? , 2003, Risk analysis : an official publication of the Society for Risk Analysis.
[39] E. S. Pearson,et al. On the Problem of the Most Efficient Tests of Statistical Hypotheses , 1933 .
[40] Joseph C. Gardiner,et al. Estimating medical costs from a transition model , 2008, 0805.2496.
[41] A. Briggs,et al. Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'. , 1997, Health Economics.
[42] D Polsky,et al. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. , 1997, Health economics.
[43] D. Horvitz,et al. A Generalization of Sampling Without Replacement from a Finite Universe , 1952 .
[44] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[45] S. Stearns,et al. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. , 1996, Statistics in medicine.
[46] A H Briggs,et al. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.
[47] H. Bang. Medical cost analysis: application to colorectal cancer data from the SEER Medicare database. , 2005, Contemporary clinical trials.
[48] Yijian Huang,et al. Cost analysis with censored data. , 2009, Medical care.
[49] Anastasios A. Tsiatis,et al. Estimating medical costs with censored data , 2000 .
[50] E. S. Pearson,et al. On the Problem of the Most Efficient Tests of Statistical Hypotheses , 1933 .
[51] H Zhao,et al. On Estimating Medical Cost and Incremental Cost‐Effectiveness Ratios with Censored Data , 2001, Biometrics.
[52] Daniel H. Wagner. Nonlinear Functional Versions of the Neyman–Pearson Lemma , 1969 .
[53] M. Pagano,et al. Survival analysis. , 1996, Nutrition.